FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like South Africa’s MCC Issues Draft Guideline on Quality Manuals May 4, 2017 Australia’s TGA Re-Tests COVID-19 Antibody Tests July 7, 2020 DHS Flags Hacking Risk in Philips’ Radiation Monitoring App September 12, 2017